Controlled Release Drug Delivery Market Latest Developments & Future Trends

The global controlled release drug delivery market size is estimated to reach USD 69.8 billion by 2027 registering a CAGR of 7.8% during the forecast period, according to a new report by Grand View Research, Inc. The benefits associated with controlled release drug delivery systems, such as increased therapeutic efficacy, less side effects, and low treatment cost are the factors driving the market growth.

These technologies offer various benefits over traditional delivery forms, such as reduced dosage and dosage frequency, enhanced patient compliance, less gastrointestinal side effects, uniform drug effect, improved drug efficacy and safety, and reduced fluctuation of plasma drug levels.

Presence of multiple in-vivo biological barriers that affects the absorption, bioavailability, and stability of the drug has open wide horizon for the controlled release drug delivery products. For instance, controlled release drug delivery system has enabled delivery of even large and complex molecules such as DNA/RNA, proteins and polypeptides. Additionally, the rising awareness among healthcare professionals, regarding the advantage of controlled release drug delivery systems over conventional systems is expected to drive the demand for the market in long run.

Rapidly increasing geriatric and pediatric population is one of the major factors fueling the demand for controlled release drug delivery systems, due to high cases prescription non-adherence in this age-group. Innovations in various drug delivery systems has been providing geriatric and pediatric population with easy solutions, which are further propelling the market. Controlled release of drug delivery systems can be altered according to required dosage over a specific period of time.

Full Research Report On Controlled Release Drug Delivery Market Visit Here: https://www.grandviewresearch.com/industry-analysis/controlled-release-drug-delivery-market

Controlled Release Drug Delivery Market Report Highlights

• Based on application, oral controlled release systems held the largest market share in 2019 owing to increasing usage and ease of convenience offered for administration of medication
• Targeted drug delivery is poised to be the fastest growing technology segment during the forecast period owing to various benefits of the technology, such as increased safety and therapeutic efficacy
• Osmotic delivery is projected to witness the fastest CAGR in the activation modulation drug delivery systems during the forecast period, due to the ability of this release mechanism to not be affected by various factors, such as pH, food consumption, and gastrointestinal motility
• North America held the largest market share in 2019 owing to the presence of developed healthcare infrastructure facilities, increasing R&D activities and existence of major market players
• Asia Pacific is expected to post the highest CAGR during the forecast period owing to rising investments by dominant players in the region along with developments in the of pharmaceutical industry in emerging countries, such as India and China
• Some of the prominent companies operating in the controlled release drug delivery market are Orbis Biosciences, Inc.; Merck and Co., Inc.; Alkermes plc; Johnson and Johnson; Coating Place, Inc.; Corium International, Inc.; Depomed, Inc.; Pfizer, Inc; Aradigm Corporation; and Capsugel

Request a Sample Copy of the Report @ https://www.grandviewresearch.com/industry-analysis/controlled-release-drug-delivery-market/request/rs1

Controlled Release Drug Delivery Market Segmentation

Grand View Research has segmented the global controlled release drug delivery market on the basis of technology, release mechanism, application, and region:

Controlled Release Drug Delivery Technology Outlook (Revenue, USD Million, 2016 - 2027)

• Wurster Technique
• Coacervation
• Micro Encapsulation
• Implants
• Transdermal
• Targeted Delivery
• Others

Controlled Release Drug Delivery Release Mechanism Outlook (Revenue, USD Million, 2016 - 2027)

• Polymer Based Systems
• Micro Reservoir Partition Controlled Drug Delivery Systems
• Feedback Regulated Drug Delivery Systems
• Activation-modulated Drug Delivery Systems
• Osmotic Pressure Activated
• Hydrodynamic Pressure Activated
• Vapor Pressure Activated
• Mechanically Activated
• Magnetically Activated
• Chemically Activated
• pH Activated
• Hydrolysis Activated
• Enzyme Activated

Controlled Release Drug Delivery Application Outlook (Revenue, USD Million, 2016 - 2027)

• Metered Dose Inhalers
• Injectable
• Transdermal and Ocular Patches
• Infusion Pumps
• Oral Controlled-drug Delivery Systems
• Drug Eluting Stents

Controlled Release Drug Delivery Region Outlook (Revenue, USD Million, 2016 - 2027)

• North America
• U.S.
• Canada
• Europe
• Germany
• UK
• France
• Italy
• Russia
• Switzerland
• Netherland
• Sweden
• Spain
• Belgium
• Asia Pacific
• China
• Japan
• India
• Thailand
• South Korea
• Singapore
• Philippines
• Vietnam
• Indonesia
• Malaysia
• Latin America
• Brazil
• Mexico
• Argentina
• Colombia
• Chile
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE
• Israel
• Kuwait

About Grand View Research        

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more info visit @ https://www.grandviewresearch.com